• Thurs news: Moderna targets $1.1B in R&D spending cuts. Gene therapy startup emerges. J&J leads $50M financing for imaging company. Sanofi gets into radioligands. GSK’s mRNA flu vax trial. See more on our front page

dividend

  1. A better outlook for 2018 from Lilly

    After raising the quarterly dividend recently, Lilly has provided outlook for 2018 and expects recently launched products to drive revenue. Dave Ricks says ""Looking to the future, the potential of our pipeline remains strong."
    • anonymous
    • Thread
    • dividend eli lilly guidance outlook pipeline
    • Replies: 4
    • Forum: Eli Lilly
Top Bottom
Back